Advertisement

Patsy Newitt

Private equity and artificial intelligence are two of the most controversial issues in gastroenterology, according to five gastroenterologists who spoke to Becker's ASC Review.

The consolidation of corporate networks and the need for financial support to meet service requirements has changed the way anesthesia services are negotiated, Tony Mira, Anesthesia Business Consultants' president and CEO, said in a recent blog post. 

Advertisement

From the American College of Gastroenterology to Medtronic, here are four leadership appointments from gastroenterology companies since Oct. 1:

Evoke Pharma, which focuses on treating gastrointestinal diseases, released its third quarter financial results Nov. 10. 

Advertisement